Principles of clinical pathology for toxicology studies

Principles and Methods of Toxicology: Fifth Edition

Volumn , Issue , 2007, Pages 1317-1358

  Hall, Robert L ^a   Everds, Nancy E ^b  

^a 206 Carnegie Center   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85132688600     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (167)

1. Beutler, E. et al., Williams Hematology, 6th ed., McGraw-Hill, New York, 2001.
2. Burtis, C. A., Ashwood, E. R., and Bruns, D. E., Tietz Textbook of Clinical Chemistry and Molecular Diagnosis, 4th ed., W.B. Saunders, Philadelphia, PA, 2005.
3. Hasegawa, A. and Furuhama, K, Atlas of the Hematology of the Laboratory Rat, Elsevier, Amsterdam, 1998.
4. Feldman, B. F., Zinkl, J. G., and Jain, N. C., Schalm's Veterinary Hematology, 5th ed., Lippincott Williams & Wilkins, Baltimore, MD, 2000.
5. Kaneko, J. J., Harvey, J. W., and Bruss, M. L., Clinical Biochemistry of Domestic Animals, 5th ed., Academic Press, San Diego, CA, 1997.
6. Kaplan, L. A., Pesce, A., and Kazmierczak, S., Clinical Chemistry: Theory, Analysis, Correlation, 4th ed., Mosby, St. Louis, MO, 2003.
7. Loeb, W. F. and Quimby, F. W., The Clinical Chemistry of Laboratory Animals, 2nd ed., Taylor & Francis, Philadelphia, PA, 1999.
8. Latimer, K. S. et al., Duncan & Prasse's Veterinary Laboratory Medicine: Clinical Pathology, 4th ed., Iowa State Press, Ames, IA, 2003.
9. Greer, J. P., Foerster, J., and Lukens, J. N., Wintrobe's Clinical Hematology, 11th ed., Lippincott Williams & Wilkins, Baltimore, MD, 2003.
10. Thrall, M. A. et al., Veterinary Hematology & Clinical Chemistry, Lippincott Williams & Wilkins, Baltimore, MD, 2004.
11. Hall, R. L., Clinical pathology for preclinical safety assessment: current global guidelines, Toxicol. Pathol., 20, 472, 1992.
12. Weingand, K. et al., Harmonization of animal clinical pathology testing in toxicity and safety studies, Fundam. Appl. Toxicol, 29, 198, 1996.
13. Godsafe, P. A. and Singleton, B. K., The use of the whole blood Thrombotest (1/51) as a routine monitor of vitamin K-dependent blood coagulation factor levels in the rat, Comp. Haematol. Int., 2, 51, 1992.
14. Frith, C. H., Ward, J. M., and Chandra, M., The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats, Toxicol. Pathol., 21, 206, 1993.
15. Boone, L. et al., Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies, Vet. Clin. Pathol, 34, 182, 2005.
16. Carakostas, M. C., What is serum ornithine decarboxylase?, Clin. Chem., 34, 2606, 1988.
17. Clemo, F. A. S., Urinary enzyme evaluation of nephrotoxicity in the dog, Toxicol. Pathol., 26, 29, 1998.
18. Kolaja, G. J. et al., The use of sodium dodecyl sulfate-polyacrylamide gel electrophoresis to detect renal damage in Sprague-Dawley rats treated with gentamicin sulfate. Toxicol. Pathol., 20, 603, 1992.
19. Stonard, M. D. et al., Urinary enzymes and protein patterns as indicators of injury to different regions of the kidney, Fundam. Appl. Toxicol., 9, 339, 1987.
20. Price, R. G., Urinary enzymes, nephrotoxicity, and renal disease, Toxicologist, 23, 99, 1982.
21. Davies, D. T., Enzymology in preclinical safety evaluation, Toxicol. Pathol., 20, 501, 1992.
22. Matsuzawa, T., Nomura, M., and Unno, T., Clinical pathology reference ranges of laboratory animals, J. Vet. Med. Sci., 55, 351, 1993.
23. Stromberg, P. C., Large granular lymphocyte leukemia in F344 rats, Am. J. Pathol., 119, 517, 1985.
24. Butterfield, L., Are there just 'races' (subspecies) of cynomolgus monkeys or should the name of Macaca irus be revived?, Lab. Primate Newslett., 36, 19, 1997.
25. Apostolou, A., Saidt, L., and Brown, W. R., Effect of overnight fasting of young rats on water consumption, body weight, blood sampling, and blood composition, Lab. Anim. Sci., 26, 959, 1976.
26. Kimball, J. P. et al., Short-term carbon dioxide/oxygen anesthesia for laboratory rats and mice, Clin. Chem., 41, S163, 1995.
27. Maejima, K. and Nagase, S., Effect of starvation and refeeding on the circadian rhythms of hematological and clinico-biochemical values and water intake of rats, Exp. Anim. Jpn., 40, 389, 1991.
28. Matsuzawa, T. and Sakazume, M., Effects of fasting on haematology and clinical chemistry values in the rat and dog, Comp. Haematol. Int., 4, 152, 1994.
29. Thompson, M. B., Avoiding pitfalls in clinical chemistry: quality control is not quality assurance, in Managing Conduct and Data Quality of Toxicology Studies: Sharing Perspectives, Expanding Horizons, Conference Proceedings, Princeton Scientific, Princeton, NJ, 1986, p. 199.
30. Bennett, J. S. et al., Effects of ketamine hydrochloride on serum biochemical and hematological variables in rhesus monkeys (Macaca mulatto), Vet. Clin. Pathol, 21, 15, 1992.
31. Dameron, G. W. et al., Effect of bleeding site on clinical laboratory testing of rats: orbital venous plexus versus posterior vena cava, Lab. Anim. Sci, 42, 299, 1992.
32. Khan, K. N., Effect of bleeding site on clinical pathologic parameters in Sprague-Dawley rats: retro-orbital venous plexus versus abdominal aorta, Contemp. Top, 35, 63, 1996.
33. Matsuzawa, T. et al., A comparison of the effect of bleeding site on haematological and plasma chemistry values of F344 rats: the inferior vena cava, abdominal aorta, and orbital venous plexus, Comp. Haematol. Int., 4, 207, 1994.
34. Millis, D. L. et al., Comparison of coagulation test results for blood samples obtained by means of direct venipuncture and through a jugular vein catheter in clinically normal dogs, J. Am. Vet. Med. Assoc, 207, 1311, 1995.
35. Neptun, D. A., Smith, C. N., and Irons, R. D., Effect of sampling site and collection methods on variations in baseline clinical pathology parameters in Fischer-344 rats. I. Clinical chemistry, Fundam. Appl. Toxicol, 5, 1180, 1985.
36. Roncaglioni, M. C., de Gaetano, G., and Donati, M. B., Some aspects of hematological toxicity in animals, in Animals in Toxicological Research, Bartosek, I., Ed., Raven Press, New York, 1982, p. 77.
37. Smith, C. N., Neptun, D. A., and Irons, R. D., Effect of sampling site and collection methods on variations in baseline clinical pathology parameters in Fischer-344 rats. II. Clinical hematology, Fundam. Appl. Toxicol, 7, 658, 1986.
38. Stringer, S. K. and Seligmann, B. E., Effects of two injectable anesthetic agents on coagulation assays in the rat, Lab. Anim. Sci., 46, 430, 1996.
39. Suber, R. L. and Kodell, R. L., The effect of three phlebotomy techniques on hematological and clinical chemical evaluation in Sprague-Dawley rats, Vet. Clin. Pathol, 14, 23, 1985.
40. Upton, P. K. and Morgan, D. J., The effect of sampling technique on some blood parameters in the rat, Lab. Anim., 9, 85, 1975.
41. Nemzek, J. A. et al., Differences in normal values for murine white blood cell counts and other hematological parameters based on sampling site, Inflamm. Res, 50, 523, 2001.
42. Schnell, M. A. et al., Effect of blood collection technique in mice on clinical pathology parameters, Hum. Gene Ther, 13, 155, 2002.
43. Sawyer, M. L., Douglas, S. E., and Mielke, P. M., Blood collection via the jugular vein in rats, Contemp. Top., 36, 64, 1997.
44. Dufour, D. R., Sources and control of analytical variation, in Clinical Chemistry: Theory, Analysis, Correlation, 3rd ed., Kaplan, L. A. and Pesce, A. J., Eds., Mosby, St. Louis, MO, 1996, p. 65.
45. Feldman, B. F. and O'Neil, S., Hemolysis as a factor in clinical chemistry and hematology of the dog, Vet. Clin. Pathol, 17, 20, 1988.
46. Frank, J. J. et al., Effect of in vitro hemolysis on chemical values for serum, Clin. Chem, 24, 1966, 1978.
47. Laessig, R. H. et al., The effect of 0.1 and 1.0% erythrocytes and hemolysis on serum chemistry values, Am. J. Clin. Pathol., 66, 639, 1976.
48. Leard, B. L. et al., The effect of haemolysis on certain canine serum chemistry parameters, Lab. Anim., 24, 32, 1990.
49. Zhang, D. J. et al., Effect of serum-clot contact time on clinical chemistry laboratory results, Clin. Chem., 44, 1325, 1998.
50. Ono, T. et al., Serum-constituents analysis: effect of duration and temperature of storage of clotted blood, Clin. Chem., 27, 35, 1981.
51. Thoreson, S. I. et al., Effects of storage time on chemistry: results from canine whole blood, heparinized whole blood, serum, and heparinized plasma, Vet. Clin. Pathol, 21, 88, 1992.
52. Dodds, W. J., Hemostasis, in Clinical Biochemistry of Domestic Animals, 5th ed., Kaneko, J. J., Harvey, J. W., and Bruss, M. L., Eds., Academic Press, San Diego, CA, 1997, p. 241.
53. Scipioni, R. L. et al., Clinical and clinicopathological assessment of serial phlebotomy in the Sprague-Dawley rat, Lab. Anim. Sci., 47, 293, 1997.
54. Nahas, K. and Provost, J.-P., Blood sampling in the rat: current practices and limitations, Comp. Clin. Pathol., 11, 14, 2002.
55. Hulse, M., Feldman, S., and Bruckner, J. V., Effect of blood sampling schedules on protein drug binding in the rat, J. Pharmacol. Exp. Ther., 218, 416, 1981.
56. Passey, R. B., Quality control for the clinical chemistry laboratory, in Clinical Chemistry: Theory, Analysis, Correlation, 3rd ed., Kaplan, L. A. and Pesce, A. J., Eds., Mosby, St. Louis, MO, 1996, p. 382.
57. Westgard, J. O. and Klee, G. G., Quality assurance, in Fundamentals of Clinical Chemistry, 3rd ed., Tietz, N. W., Ed., W.B. Saunders, Philadelphia, PA, 1987, p. 238.
58. Carakostas, M. C. and Banerjee, A. K., Interpreting rodent clinical laboratory data in safety assessment studies: biological and analytical components of variation, Fundam. Appl. Toxicol., 15, 744, 1990.
59. Chanter, D. O., Tuck, M. G., and Coombs, D. W., The chances of false negative results in conventional toxicology studies with rats, Toxicologist, 43, 65, 1987.
60. NCCLS, How To Define and Determine Reference Intervals in the Clinical Laboratory: Approved Guideline. NCCLS document C28-A, National Committee for Clinical Laboratory Standards, Villanova, PA, 1995.
61. Desbiens, N. A., Turney, S. L., and Gani, K. S., Multichannel 18-test panels: Are 60% of the panels abnormal by chance? J. Lab. Clin. Med, 115, 292, 1990.
62. Hall, R. L., Lies, damn lies, and reference intervals (or hysterical control values) for clinical pathology data, Toxicol. Pathol., 25, 647, 1997.
63. Waner, T., Nyska, A., and Chen, R., Population distribution profiles of the activities of blood alanine and aspartate aminotransferase in the normal F344 inbred rat by age and sex, Lab. Anim. Sci, 25, 263, 1991.
64. Weil, C. S. and Carpenter, C. P., Abnormal values in control groups during repeated-dose toxicologic studies, Toxicol. Appl. Pharmacol, 14, 335, 1969.
65. Knoll, J. S., Clinical automated hematology systems, in Schalm's Veterinary Hematology, 5th ed., Feldman, B. F., Zinkl, J. G., and Jain, N. C., Eds., Lippincott Williams & Wilkins, Boston, MA, 2000.
66. Szaflarski, N. L., Physiologic effects of normovolemic anemia: implications for clinical monitoring, AACN Clin. Issues, 7, 198, 1996.
67. McGrath, J. P., Assessment of hemolytic and hemorrhagic anemias in preclinical safety assessment studies, Toxicol. Pathol., 21, 158, 1993.
68. Beutler, E., Glucose-6-phosphate dehydrogenase deficiency and other enzyme abnormalities, in Williams Hematology, 5th ed., Beutler, E. et al., Eds., McGraw-Hill, New York, 1995, p. 564.
69. McGrath, J. P. et al., Oxidative erythrocytic injury in preclinical toxicity testing, Vet. Pathol., 30, 429, 1993.
70. Mansouri, A. and Luri, A. A., Concise review: methemoglobinemia, Am. J. Hematol., 42, 7, 1993.
71. Davis, J. A., Greenfield, R. E., and Brewer, T. G., Benzocaine-induced methemoglobinemia attributed to topical application of the anesthetic in several laboratory animal species, Am. J. Vet. Res., 54, 1322, 1993.
72. Stolk, J. M. and Smith, R. P., Species differences in methemoglobin reductase activity, Biochem. Pharmacol., 15, 343, 1966.
73. Packman, C. H. and Leddy, J. P., Drug-related immune hemolytic anemia, in Williams Hematology, 5th ed., Beutler, E. et al., Eds., McGraw-Hill, New York, 1995, p. 691.
74. Wardrop, K. J., The Coombs' test in veterinary medicine: past, present, future, Vet. Clin. Pathol., 34, 325, 2005.
75. Donovan, J. C. et al., Hematologic characterization of naturally occurring malaria (Plasmodium inui) in cynomolgus monkeys (Macaca fascicularis), Lab. Anim. Sci., 33, 86, 1983.
76. Riley, J. H., Safety testing of immunomodulatory drugs in primates: difficulties in differentiating test article effects from occult diseases-malaria, Toxicol. Pathol., 33, 802, 2005.
77. Erslev, A. J., Anemia of chronic disease, in Williams Hematology, 5th ed., Beutler, E. et al., Eds., McGraw-Hill, New York, 1995, p. 518.
78. Feldman, B. F., Kaneko, J. J., and Farver, T. B., Anemia of inflammatory disease in the dog: clinical characterization, Am. J. Vet. Res., 42, 1109, 1981.
79. Feldman, B. F., Kaneko, J. J., and Farver, T. B., Anemia of inflammatory disease in the dog: ferrokinetics of adjuvant-induced anemia, Am. J. Vet. Res., 42, 583, 1981.
80. Caro, J. and Erslev, A. J., Anemia of chronic renal failure, in Williams Hematology, 5th ed., Beutler, E. et al., Eds., McGraw-Hill, New York, 1995, p. 456.
81. Palek, J., Acanthocytosis, stomatocytosis, and related disorders, in Williams Hematology, 5th ed., Beutler, E. et al., Eds., McGraw-Hill, New York, 1995, p. 557.
82. Erslev, A J., Anemia of endocrine disorders, in Williams Hematology, 5th ed., Beutler, E. et al., Eds., McGraw-Hill, New York, 1995, p. 462.
83. Shadduck, R. K., Aplastic anemia, in Williams Hematology, 5th ed., Beutler, E. et al., Eds., McGraw-Hill, New York, 1995, p. 238.
84. Weiss, D. J. and Klausner, J. S., Drug-associated aplastic anemia in dogs: eight cases (1984-1988), J. Am. Vet. Med. Assoc., 196, 472, 1990.
85. Erslev, A. J., Pure red cell aplasia, in Williams Hematology, 5th ed., Beutler, E. et al., Eds., McGraw-Hill, New York, 1995, p. 448.
86. Babior, B. M., The megaloblastic anemias, in Williams Hematology, 5th ed., Beutler, E. et al., Eds., McGraw-Hill, New York, 1995, p. 471.
87. Wixson, S. K. and Griffith, J. W., Nutritional deficiency anemias in nonhuman primates, Lab. Anim. Sci., 36, 231, 1986.
88. Cazzola, M., Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin, Med. Oncol., 17, 11, 2000.
89. Kurzrock, R., The role of cytokines in cancer-related fatigue, Cancer, 92, 1684, 2001.
90. Weiss, D. J., Leukocyte response to toxic injury, Toxicol. Pathol., 21, 135, 1993.
91. Bloom, J. C. et al., Cephalosporin-induced immune cytopenia in the dog: demonstration of erythrocyte-, neutrophil-, and platelet-associated IgG following treatment with cefazedone, Am. J. Hematol., 28, 71, 1988.
92. Lorenz, M. et al., Atypical antipsychotic-induced neutropenia in dogs, Toxicol. Appl. Pharmacol., 155, 227, 1999.
93. Iverson, S., Zahid, N., and Uetrecht, J. P., Predicting drug-induced agranulocytosis: Characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis, Chem. Biol. Interact., 142, 175, 1002.
94. Williams, W. J., Secondary thrombocytosis, in Williams Hematology, 5th ed., Beutler, E. et al., Eds., McGraw-Hill, New York, 1995, p. 1361.
95. Beguin, Y., Erythropoietin and platelet production, Haematologica, 84, 541, 1999.
96. Boon, G. D., An overview of hemostasis, Toxicol. Pathol., 21, 170, 1993.
97. George, J. N., El-Harake, M., and Aster, R. H., Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms, in Williams Hematology, 5th ed., Beutler, E. et al., Eds., McGraw-Hill, New York, 1995, p. 1315.
98. Martin, R. A. et al., Differential analysis of animal bone marrow by flow cytometry, Cytometry, 13, 638, 1992.
99. Rebar, A. H., General responses of the bone marrow to injury, Toxicol. Pathol., 21, 118, 1993.
100. Bollinger, A. P., Cytologic evaluation of bone marrow in rats: indications, methods, and normal morphology, Vet. Clin. Pathol., 33, 58, 2004.
101. Jesty, J. and Nemerson, Y., The pathways of blood coagulation, in Williams Hematology, 5th ed., Beutler, E. et al., Eds., McGraw-Hill, New York, 1995, p. 1227.
102. Byars, T. D. et al., Activated coagulation time (ACT) of whole blood in normal dogs, Am. J. Vet. Res., 37, 1359, 1976.
103. Schiffer, S. P., Gillett, C. S., and Ringler, D. H., Activated coagulation time for rhesus monkeys (Macaca mulatta), Lab. Anim. Sci., 34, 191, 1984.
104. Wilkerson, R. D., Conran, P. B., and Greene, S. L., Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research, Lab. Anim. Sci., 34, 62, 1984.
105. Kurata, M. et al., Prolongation of PT and APTT under excessive anticoagulant in plasma from rats and dogs, J. Toxicol. Sci., 23, 149, 1998.
106. O'Brien, S. R., Sellers, T. S., and Meyer, D. J., Artifactual prolongation of the activated partial thromboplastin time associated with hemoconcentration in dogs, J. Vet. Int. Med., 3, 163, 1995.
107. Sherwin, J. E. and Sobenes, J. R., Liver function, in Clinical Chemistry: Theory, Analysis, Correlation, 3rd ed., Kaplan, L. A. and Pesce, A. J., Eds., Mosby, St. Louis, MO, 1996, p. 505.
108. Sturgill, M. G. and Lambert, G. H., Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring liver function, Clin. Chem., 43, 1512, 1997.
109. Carakostas, M. C. et al., Evaluating toxin-induced hepatic injury in rats by laboratory results and discriminant analysis, Vet. Pathol., 23, 264, 1986.
110. Boyd, J. W., The mechanisms relating to increases in plasma enzymes and isoenzymes in diseases of animals, Vet. Clin. Pathol., 12, 9, 1983.
111. Boyd, J. W., Serum enzymes in the diagnosis of diseases in man and animals, J. Comp. Pathol., 98, 381, 1988.
112. Keller, P., Enzyme activities in the dog: tissue analyses, plasma values, and intracellular distribution, Am. J. Vet. Res., 42, 575, 1981.
113. Clampitt, R. B. and Hart, R. J., The tissue activities of some diagnostic enzymes in ten mammalian species, J. Comp. Pathol., 88, 607, 1978.
114. Tenant, B. C., Hepatic function, in Clinical Biochemistry of Domestic Animals, 5th ed., Kaneko, J. J., Harvey, J. W., and Bruss, M. L., Eds., Academic Press, San Diego, CA, 1997, p. 327.
115. Kramer, J. W. and Hoffman, W. E., Clinical enzymology, in Clinical Biochemistry of Domestic Animals, 5th ed., Kaneko, J. J., Harvey, J. W., and Bruss, M. L., Eds., Academic Press, San Diego, CA, 1997, p. 303.
116. Solter, P. F., Clinical pathology approaches to hepatic injury, Toxicol. Pathol., 33, 9, 2005.
117. Swenson, C. L. and Graves, T. K., Absence of liver specificity for canine alanine aminotransferase, Vet. Clin. Pathol., 26, 26, 1997.
118. Watkins, J. R., Gough, A. W., and McGuire, E. J., Druginduced myopathy in beagle dogs, Toxicol. Pathol., 17, 545, 1989.
119. Slighter, R. G. et al., Enzootic hepatitis A infection in cynomolgus monkeys (Macaca fascicularis), Am. J. Primatol., 14, 73, 1988.
120. Swaim, L. D., Taylor, H. W., and Jersey, G. C., The effect of handling techniques on serum ALT activity in mice, J. Appl. Toxicol., 5, 160, 1985.
121. Dooley, J. F., Sorbitol dehydrogenase and its use in toxicology testing in lab animals, Lab. Anim., 13, 20, 1984.
122. 6 in the toxicity of hydrazines, Ann. N.Y. Acad. Sci., 166, 136, 1969.
123. Dhami, M. S. I. et al., Decreases in aminotransferase activity of serum and various tissues in the rat after cefazolin treatment, Clin. Chem., 25, 1263, 1979.
124. Waner, T. et al., Gingival hyperplasia in dogs induced by oxodipine, a calcium channel blocker, Toxicol. Pathol., 16, 327, 1988.
125. Hoffman, W. E. et al, Automated and semiautomated analysis of rat alkaline phosphatase isoenzymes, Toxicol. Pathol., 22, 633, 1994.
126. Hoffman, W. E. and Solter, P. F., Alkaline phosphatase isoenzymes: biochemistry and clinical evaluation in domestic and laboratory animals, Curr. Top. Vet. Res., 1, 171, 1994.
127. Waner, T. and Nyska, A., The influence of fasting on blood glucose, triglycerides, cholesterol, and alkaline phosphatase in rats, Vet. Clin. Pathol., 23, 78, 1994.
128. Solter, P. F. et al., Hepatic total 3a-hydroxy bile acids concentration and enzyme activities in prednisone-treated dogs, Am. J. Vet. Res., 55, 1086, 1994.
129. Leonard, T. B., Neptun, D. A., and Popp, J. A., Serum gamma glutamyl transferase as a specific indicator of bile duct lesions in the rat liver, Am. J. Pathol., 116, 262, 1984.
130. Goldberg, D. M., The expanding role of microsomal enzyme induction and its implications for clinical chemistry, Clin. Chem., 26, 691, 1980.
131. Carakostas, M. C., Power, R. J., and Banerjee, A. K., Serum 5'-nucleotidase activity in rats: a method for automated analysis and criteria for interpretation, Vet. Clin. Pathol., 19, 109, 1990.
132. Jaynes, P. K., Antiepileptic drug therapy: the laboratory effects on enzyme induction, Lab. Manage., March, 40, 1984.
133. Center, S. A. et al., Bile acid concentrations in the diagnosis of hepatobiliary disease in the dog, J. Am. Vet. Med. Assoc., 187, 935, 1985.
134. Bovee, K. C., Renal function and laboratory evaluation, Toxicol. Pathol., 14, 26, 1986.
135. Finco, D. R. and Duncan, J. R., Evaluation of blood urea nitrogen and serum creatinine concentrations as indicators of renal dysfunction: a study of 111 cases and a review of related literature, J. Am. Vet. Med. Assoc., 168, 593, 1976.
136. Loeb, W. F., The measurement of renal injury, Toxicol. Pathol., 26, 26, 1998.
137. Perrone, R. D., Madias, N. E., and Levey, A. S., Serum creatinine as an index of renal function: new insights into old concepts, Clin. Chem., 38, 1933, 1992.
138. Stonard, M. D., Assessment of renal function and damage in animal species, J. Appl. Toxicol., 10, 267, 1990.
139. Bovee, K. C. and Joyce, T., Clinical evaluation of glomerular function: 24-hour creatinine clearance in dogs, J. Am. Vet. Med. Assoc., 174, 488, 1979.
140. Kaneko, J. J., Serum proteins and the dysproteinemias, in Clinical Biochemistry of Domestic Animals, 5th ed., Kaneko, J. J., Harvey, J. W., and Bruss, M. L., Eds., Academic Press, San Diego, CA, 1997, p. 117.
141. Burton, S. A. et al., C-reactive protein concentration in dogs with inflammatory leukograms, Am. J. Vet. Res., 55, 613, 1994.
142. Solter, P. F. et al., Haptoglobin and ceruloplasmin as determinants of inflammation in dogs, Am. J. Vet. Res, 52, 1738, 1991.
143. Ceron, J. J., Eckersall, P. D., and Martinez-Subiela, S., Acute phase proteins in dogs and cats: current knowledge and future perspectives, Vet. Clin. Pathol., 34, 85, 2005.
144. Bruss, M. L., Lipids and ketones, in Clinical Biochemistry of Domestic Animals, 5th ed., Kaneko, J. J., Harvey, J. W., and Bruss, M. L., Eds., Academic Press, San Diego, CA, 1997, p. 83.
145. Bauer, J. E., Comparative lipid and lipoprotein metabolism, Vet. Clin. Pathol., 25, 49, 1996.
146. Rosol, T. J. and Capen, C. C., Calcium-regulating hormones and diseases of abnormal mineral (calcium, phosphorus, magnesium) metabolism, in Clinical Biochemistry of Domestic Animals, 5th ed., Kaneko, J. J., Harvey, J. W., and Bruss, M. L., Eds., Academic Press, San Diego, CA, 1997, p. 619.
147. Christenson, R. H. and Azzazy, H. M. E., Biochemical markers of the acute coronary syndromes, Clin. Chem., 44, 1855, 1998.
148. Beck, M. L. et al., Cardiac troponin T is a sensitive and specific biomarker of cardiac injury in laboratory animals, Clin. Chem., 43, S192, 1997.
149. Dameron, G. W. et al., Tissue and species specificity of two generations of cardiac troponin-T immunoassays, Clin. Chem., 43, 5192, 1997.
150. Evans, G. O., Biochemical assessment of cardiac function and damage in animal species, J. Appl. Toxicol., 11, 15, 1990.
151. Hossein-Nia, M. et al., Creatine kinase MB isoforms and troponins T and I: sensitive markers of myocardial damage in pre-clinical studies. Clin. Chem, 42, 5241, 1996.
152. O'Brien, P. J., Landt, Y., and Ladenson, J. H., Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay, Clin. Chem., 43, 2333, 1997.
153. Vail, D. M., Allen, T. A., and Weiser, G., Applicability of leukocyte esterase test strip in detection of canine pyuria, J. Am. Vet. Med. Assoc, 189, 1451, 1986.
154. Fettman, M. J., Evaluation of the usefulness of routine microscopy in canine urinalysis, J. Am. Vet. Med. Assoc., 190, 892, 1987.
155. Cohen, S. M., Comparative pathology of proliferative lesions of the urinary bladder, Toxicol. Pathol., 30, 663, 2002.
156. Ellis, B. G., Price, R. G., and Topham, J. G., The effect of papillary damage by ethyleneimine on kidney function and some urinary enzymes in the dog, Chem. Biol. Interact., 7, 132, 1973.
157. Ellis, B. G., Price, R. G., and Topham, J. C., The effect of tubular damage by mercuric chloride on kidney function and some urinary enzymes in the dog, Chem. Biol. Interact., 7, 101, 1973.
158. Grauer, G. F. et al., Estimation of quantitative enzymuria in dogs with gentamicin-induced nephrotoxicosis using urine enzyme/creatinine ratios from spot urine samples, J. Vet. Intern. Med., 9, 324, 1985.
159. Greco, D. S. et al., Urinary gamma-glutamyl transpeptidase activity in dogs with gentamicin-induced nephrotoxicity, Am. J. Vet. Res., 46, 2332, 1985.
160. McAuley, F. T. et al., The predictive value of enzymuria in cyclosporin A-induced renal toxicity in the rat, Toxicol. Lett., 32, 163, 1986.
161. Center, S. A. et al., 24-Hour urine protein/creatinine ratio in dogs with protein-losing nephropathies, J. Am. Vet. Med. Assoc., 187, 820, 1985.
162. Grauer, G. F., Thomas, C. B., and Eicker, S. W., Estimation of quantitative proteinuria in the dog, using the protein-tocreatinine ratio from a random, voided sample, Am. J. Vet. Res., 46, 2116, 1985.
163. Hall, R. L., Wilke,W. L., and Fettman, M. J., The progression of adriamycin-induced nephrotic syndrome in rats and the effect of captopril, Toxicol. Appl. Pharmacol, 82, 164, 1986.
164. White, J. V. et al., Use of protein-to-creatinine ratio in a single urine specimen for quantitative estimation of canine proteinuria, J. Am. Vet. Med. Assoc, 185, 882, 1984.
165. 2-microglob-ulin: its significance in the evaluation of renal function, Kidney Int, 32, 635, 1987.
166. 2-microglobulin in urine and in serum. I. Development of an immunoassay based on latex particles agglutination, J. Appl. Toxicol., 6, 185, 1986.
167. 2-microglobulin in urine and in serum. II. Application of its urinary measurement to selected nephrotoxicity models, J. Appl. Toxicol., 6, 191, 1986.